Despite no significant difference in the expression of other SLC38 family members between GC and normal samples in TCGA data using GEPIA, SLC38A1 and SLC38A2 were correlated with a poor prognosis in GC patients and regulated proliferation, invasion, and migration of GC cells (13, 30). The gene discussed is SLC38A2; the disease is gastric cancer.